Debates on the safety and effectiveness of vaccines have captured the public’s attention recently. A vaccine is a preventative strategy for certain diseases and has helped in the eradication of diseases such as Smallpox. But did you know how long it usually takes to get a vaccine to the market? On average, a vaccine may reach target users 15-20 years after their discovery. However, this changed tremendously during the COVID-19 pandemic.
In August 2021, less than 2 years after the virus was discovered; the COVID-19 vaccine was made available to the public. How was this made possible? The innovators of the vaccines (e.g., Pfizer, Moderna, etc.) followed an Adaptive Trial Design. This shift from the conventional trial process has dramatically shortened the vaccine timeline. Adaptive Trial Design uses a change-as-you-go strategy where the parameters and conditions are changed and adjusted depending on the new data gathered during the study. Several hypotheses can be tested simultaneously through this design which means data collection can be tedious and complex. However, not only does this complex trial design shorten the timeline but it is also a cost-effective alternative. So Adaptive Trial Design is a new approach that helps reach clinical trial goals – providing safe and effective intervention (drugs, vaccines, therapies) – that saves time and money.
How can the process be streamlined without trading off its reliability and effectiveness? Efficient Data Management. The bottleneck in almost every complex research is how the data is collected, segregated, managed, and utilized. However, this can also lay the groundwork for a successful trial if done with efficiency. Adaptive clinical trials can have the most complex data possible, so here are ways to help you streamline your data management:
The goal of any therapeutic such as a vaccine/drug is to be effectively delivered and distributed to the general population as quickly as possible to prevent and treat various diseases. Among others, Data Management is one of the critical aspects to consider during the development of such therapeutics.
References:
https://www.cdc.gov/vaccines/basics/test-approve.html
https://cpp-hov.netlify.app//vaccines-101/how-are-vaccines-made/vaccine-development-testing-and-regulation
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Pfizer-BioNTech.html
https://clinicaltrials.gov/ct2/show/NCT04894435